BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30133046)

  • 1. Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.
    Dreher C; Oberhollenzer J; Meissner JE; Windschuh J; Schuenke P; Regnery S; Sahm F; Bickelhaupt S; Bendszus M; Wick W; Unterberg A; Zaiss M; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Paech D
    J Magn Reson Imaging; 2019 Mar; 49(3):777-785. PubMed ID: 30133046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T.
    Meissner JE; Korzowski A; Regnery S; Goerke S; Breitling J; Floca RO; Debus J; Schlemmer HP; Ladd ME; Bachert P; Adeberg S; Paech D
    J Magn Reson Imaging; 2019 Oct; 50(4):1268-1277. PubMed ID: 30864193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
    Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
    Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
    Paech D; Windschuh J; Oberhollenzer J; Dreher C; Sahm F; Meissner JE; Goerke S; Schuenke P; Zaiss M; Regnery S; Bickelhaupt S; Bäumer P; Bendszus M; Wick W; Unterberg A; Bachert P; Ladd ME; Schlemmer HP; Radbruch A
    Neuro Oncol; 2018 Nov; 20(12):1661-1671. PubMed ID: 29733378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct saturation-corrected chemical exchange saturation transfer MRI of glioma: Simplified decoupling of amide proton transfer and nuclear overhauser effect contrasts.
    Yuwen Zhou I; Wang E; Cheung JS; Lu D; Ji Y; Zhang X; Fulci G; Sun PZ
    Magn Reson Med; 2017 Dec; 78(6):2307-2314. PubMed ID: 29030880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
    Regnery S; Adeberg S; Dreher C; Oberhollenzer J; Meissner JE; Goerke S; Windschuh J; Deike-Hofmann K; Bickelhaupt S; Zaiss M; Radbruch A; Bendszus M; Wick W; Unterberg A; Rieken S; Debus J; Bachert P; Ladd M; Schlemmer HP; Paech D
    Oncotarget; 2018 Jun; 9(47):28772-28783. PubMed ID: 29983895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T.
    Wu Y; Wood TC; Arzanforoosh F; Hernandez-Tamames JA; Barker GJ; Smits M; Warnert EAH
    MAGMA; 2022 Feb; 35(1):63-73. PubMed ID: 34994858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of 3 T APT-CEST in Healthy Volunteers and Patients With Brain Glioma.
    Wamelink IJHG; Kuijer JPA; Padrela BE; Zhang Y; Barkhof F; Mutsaerts HJMM; Petr J; van de Giessen E; Keil VC
    J Magn Reson Imaging; 2023 Jan; 57(1):206-215. PubMed ID: 35633282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the effects of water proton concentration and water T
    Lee DH; Heo HY; Zhang K; Zhang Y; Jiang S; Zhao X; Zhou J
    Magn Reson Med; 2017 Feb; 77(2):855-863. PubMed ID: 26841096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T.
    Loi L; Zimmermann F; Goerke S; Korzowski A; Meissner JE; Deike-Hofmann K; Stieber A; Bachert P; Ladd ME; Schlemmer HP; Bickelhaupt S; Schott S; Paech D
    Eur J Radiol; 2020 Aug; 129():109068. PubMed ID: 32574936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma.
    Zaiss M; Windschuh J; Goerke S; Paech D; Meissner JE; Burth S; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Ladd ME; Bachert P; Radbruch A
    Magn Reson Med; 2017 Jan; 77(1):196-208. PubMed ID: 26845067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct radiofrequency saturation corrected amide proton transfer tumor MRI at 3T.
    Wu Y; Chen Y; Zhao Y; Yang S; Zhao J; Zhou J; Chen Z; Sun PZ; Zheng H
    Magn Reson Med; 2019 Apr; 81(4):2710-2719. PubMed ID: 30390326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI.
    da Silva NA; Lohmann P; Fairney J; Magill AW; Oros Peusquens AM; Choi CH; Stirnberg R; Stoffels G; Galldiks N; Golay X; Langen KJ; Jon Shah N
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1031-1040. PubMed ID: 29478081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
    Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
    Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear overhauser enhancement mediated chemical exchange saturation transfer imaging at 7 Tesla in glioblastoma patients.
    Paech D; Zaiss M; Meissner JE; Windschuh J; Wiestler B; Bachert P; Neumann JO; Kickingereder P; Schlemmer HP; Wick W; Nagel AM; Heiland S; Ladd ME; Bendszus M; Radbruch A
    PLoS One; 2014; 9(8):e104181. PubMed ID: 25111650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of offset-frequency step size and interpolation methods on chemical exchange saturation transfer MRI computation in human brain.
    Debnath A; Gupta RK; Reddy R; Singh A
    NMR Biomed; 2021 Apr; 34(4):e4468. PubMed ID: 33543519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.
    Zhang J; Zhu W; Tain R; Zhou XJ; Cai K
    Mol Imaging Biol; 2018 Aug; 20(4):623-631. PubMed ID: 29313159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.